What leadership changes will occur in the U.S. Attorney's Office for D.C. by June 30, 2025?
New leadership team announced • 25%
Fitzpatrick continues with current team • 25%
Temporary leadership changes • 25%
Other • 25%
Official announcements from the U.S. Attorney's Office or Department of Justice
DC US Attorney Matthew Graves, Lead January 6 Prosecutor, Resigns Before Trump's Inauguration
Dec 30, 2024, 07:00 PM
Matthew Graves, the U.S. Attorney for the District of Columbia who led the prosecution of over 1,000 individuals related to the January 6, 2021 Capitol attack, has announced he will resign effective January 16, 2025, just days before President-elect Donald Trump's inauguration. The United States Attorney's Office for D.C. confirmed Graves' resignation. Bridget Fitzpatrick, the principal assistant U.S. Attorney, will serve as acting U.S. Attorney upon his departure. Graves' tenure included overseeing the largest investigation in the Department of Justice's history addressing the events of January 6.
View original story
Another Biden appointee • 25%
Bridget M. Fitzpatrick • 25%
A Trump appointee • 25%
Other • 25%
No Change Announced • 25%
Kash Patel Appointed • 25%
Christopher Wray Retained • 25%
New Nominee Announced • 25%
Pam Bondi confirmed • 25%
Another Republican appointee • 25%
Current leadership remains • 25%
Other • 25%
New Deputy Director appointed • 25%
No leadership changes • 25%
Both Director and Deputy Director replaced • 25%
New Director appointed • 25%
Minor changes • 25%
Major reshuffle • 25%
Other • 25%
No changes • 25%
Other changes • 25%
Director replaced • 25%
No leadership changes • 25%
Deputy leadership changes • 25%
No changes • 25%
Minor changes • 25%
Major reshuffle • 25%
Other outcome • 25%
No significant changes • 25%
Partial changes • 25%
Unclear • 25%
Complete overhaul • 25%
Kash Patel as Director • 25%
Acting Director remains • 25%
Vacant position • 25%
New Director other than Patel • 25%
Yes • 50%
No • 50%
No significant change • 25%
Positive impact • 25%
Negative impact • 25%
Mixed impact • 25%
No significant impact • 25%
Other • 25%
Cases expedited • 25%
Cases delayed • 25%